Join our email list
|
At this initial stage in the development of DrugRanks, we would like to know how you think CBRAD could help you or your organisation. Now that you have read about our approach, please join our email list for updates, news and surveys.
|
After we have obtained the results of our first project – ranking drugs for type 2 diabetes – we will send another survey along with the diabetes drug rankings for your comments and suggestions for improvement. Whether you are an expert, medical professional or patient, completing our surveys about possible benefits to your organisation or you personally, we will welcome your help.
